Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 2,280.00
-25.00 (-1.08%)
At close: Jul 18, 2025, 3:30 PM KST
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 416.99 billion as of July 18, 2025. Its market cap has increased by 3.64% in one year.
Market Cap
416.99B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
42.62
Stock Price
2,280.00
Market Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 416.99B, an increase of 574.71%. That is a compound annual growth rate of 6.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.80T |
| Celltrion | 39.82T |
| ALTEOGEN | 26.19T |
| Yuhan | 9,866.54B |
| SK Biopharmaceuticals | 8,066.26B |
| HLB Co., Ltd. | 6,939.04B |
| Peptron | 6,861.07B |
| PharmaResearch | 5,890.93B |